153 related articles for article (PubMed ID: 16619519)
1. Absence of L1 in pancreatic masses distinguishes adenocarcinomas from poorly differentiated neuroendocrine carcinomas.
Kaifi JT; Heidtmann S; Schurr PG; Reichelt U; Mann O; Yekebas EF; Wachowiak R; Strate T; Schachner M; Izbicki JR
Anticancer Res; 2006; 26(2A):1167-70. PubMed ID: 16619519
[TBL] [Abstract][Full Text] [Related]
2. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: a single institution experience with 17 cases.
Sellner F; Sobhian B; De Santis M; Pont J; Staettner S; Sellner S; Karner J; Klimpfinger M
Eur J Surg Oncol; 2008 Feb; 34(2):191-5. PubMed ID: 17475440
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.
Sipos B; Hahn D; Carceller A; Piulats J; Hedderich J; Kalthoff H; Goodman SL; Kosmahl M; Klöppel G
Histopathology; 2004 Sep; 45(3):226-36. PubMed ID: 15330800
[TBL] [Abstract][Full Text] [Related]
4. Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors.
Shida T; Kishimoto T; Furuya M; Nikaido T; Koda K; Takano S; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Tanizawa T; Nakatani Y; Miyazaki M
Cancer Chemother Pharmacol; 2010 Apr; 65(5):889-93. PubMed ID: 19657638
[TBL] [Abstract][Full Text] [Related]
5. L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.
Kaifi JT; Zinnkann U; Yekebas EF; Schurr PG; Reichelt U; Wachowiak R; Fiegel HC; Petri S; Schachner M; Izbicki JR
World J Gastroenterol; 2006 Jan; 12(1):94-8. PubMed ID: 16440424
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine differentiation in pancreatic duct carcinoma special emphasis on duct-endocrine cell carcinoma of the pancreas.
Kamisawa T; Fukayama M; Tabata I; Isawa T; Tsuruta K; Okamoto A; Koike
Pathol Res Pract; 1996 Sep; 192(9):901-8. PubMed ID: 8950756
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas.
Borowitz MJ; Tuck FL; Sindelar WF; Fernsten PD; Metzgar RS
J Natl Cancer Inst; 1984 May; 72(5):999-1005. PubMed ID: 6371347
[TBL] [Abstract][Full Text] [Related]
8. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
Giannopoulos G; Pavlakis K; Parasi A; Kavatzas N; Tiniakos D; Karakosta A; Tzanakis N; Peros G
Anticancer Res; 2008; 28(3B):1875-81. PubMed ID: 18630474
[TBL] [Abstract][Full Text] [Related]
9. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?
Bergmann F; Ceyhan GO; Rieker RJ; Esposito I; Fischer L; Herpel E; Friess H; Schirmacher P; Kern MA
Hum Pathol; 2009 Jan; 40(1):50-7. PubMed ID: 18789481
[TBL] [Abstract][Full Text] [Related]
10. Acinar cell carcinoma of the pancreas: is the absence of neuroendocrine component related to a more malignant behavior?
Machado MC; Machado MA; Perini MV; Herman P; Jukemura J; Leite KR; Bacchella T
Hepatogastroenterology; 2008; 55(82-83):708-10. PubMed ID: 18613439
[TBL] [Abstract][Full Text] [Related]
11. Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma.
Rawnaq T; Kleinhans H; Uto M; Schurr PG; Reichelt U; Cataldegirmen G; Gawad KA; Yekebas EF; Schachner M; Izbicki JR; Kaifi JT
Anticancer Res; 2009 Apr; 29(4):1195-9. PubMed ID: 19414364
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody to a human pancreatic carcinoma cell line recognizes gastrointestinal neoplasms.
Kahn HJ; Yeger H; Loftus R; Goldrosen MH
Am J Pathol; 1989 Mar; 134(3):641-9. PubMed ID: 2466406
[TBL] [Abstract][Full Text] [Related]
13. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
[TBL] [Abstract][Full Text] [Related]
14. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation.
Giorgadze TA; Peterman H; Baloch ZW; Furth EE; Pasha T; Shiina N; Zhang PJ; Gupta PK
Cancer; 2006 Jun; 108(3):186-97. PubMed ID: 16628655
[TBL] [Abstract][Full Text] [Related]
16. Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy.
Huszar M; Moldenhauer G; Gschwend V; Ben-Arie A; Altevogt P; Fogel M
Hum Pathol; 2006 Aug; 37(8):1000-8. PubMed ID: 16867862
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic acinar cell carcinoma with endocrine differentiation: immunohistochemical and ultrastructural analyses.
Tobita K; Kijima H; Chino O; Dowaki S; Kashiwagi H; Tanaka M; Ohtani Y; Inokuchi S; Makuuchi H
Anticancer Res; 2001; 21(3C):2131-4. PubMed ID: 11501836
[TBL] [Abstract][Full Text] [Related]
18. L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors.
Kim HS; Yi SY; Jun HJ; Ahn JS; Ahn MJ; Lee J; Kim Y; Cui ZY; Hong HJ; Kim JM; Li S; Hwang IG; Park K
APMIS; 2009 Feb; 117(2):140-6. PubMed ID: 19239436
[TBL] [Abstract][Full Text] [Related]
19. Poorly differentiated endocrine carcinoma and intraductal papillary-mucinous neoplasm of the pancreas: Description of an unusual case.
Stukavec J; Jirasek T; Mandys V; Denemark L; Havluj L; Sosna B; Kosmahl M; Zadorova Z
Pathol Res Pract; 2007; 203(12):879-84. PubMed ID: 17936521
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
